Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study

AIMS: Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i) represent a unique class of anti‐hyperglycaemic agents for type 2 diabetes mellitus that selectively inhibit renal glucose reabsorption, thereby increasing urinary excretion of glucose. Several studies have demonstrated the cardioprotect...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Antohi, Elena‐Laura, Inciardi, Riccardo M., Mazzeo, Pietro, Coiro, Stefano, Ishihara, Shiro, Petroni, Renata, Monitillo, Francesco, Leone, Marta, Triggiani, Marco, Sarwar, Chaudhry M.S., Dungen, Hans‐Dirk, Talha, Khawaja M., Brunetti, Natale D., Butler, Javed, Nodari, Savina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192273/
https://www.ncbi.nlm.nih.gov/pubmed/36924023
http://dx.doi.org/10.1002/ehf2.14331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192273/
https://www.ncbi.nlm.nih.gov/pubmed/36924023
http://dx.doi.org/10.1002/ehf2.14331

Ejemplares similares